CORPORATE-SPONSORED SYMPOSIUM FROM GENENTECH, A MEMBER OF THE ROCHE GROUP
HELD IN CONJUNCTION WITH THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE® (AAIC)
It's a Matter of Time
Understanding Timely and Appropriate Intervention for Patients With Early Alzheimer's Disease
 
 
 
This program is subject to the General Data Protection Regulation (GDPR), and registration is currently open only to residents of non-EU countries.
Early recognition of cognitive impairment may enable timely diagnosis and initiation of appropriate interventions that may prolong patient independence and maximize treatment options and planning. This program examines barriers to and the rationale for early diagnosis by comparing two patient cases with and without timely intervention. Space is limited; please preregister.
Date
Monday, July 15, 2019
Registration
12:00 PM–12:15 PM
Symposium
12:15 PM–1:45 PM
Location
Platinum Ballroom
JW Marriott Los Angeles L.A. LIVE
900 West Olympic Boulevard
Los Angeles, CA 90015
COMPLIMENTARY
LUNCH WILL
BE SERVED
Moderator
Rachelle Doody
Rachelle Doody, MD, PhD
Global Head of Neurodegeneration
Alzheimer's Disease and Neurodegeneration
   Franchise Head
Product Development, Neuroscience
Genentech and Roche
Basel, Switzerland
Faculty
Davangere P. Devanand
Davangere P. Devanand, MBBS, MD
Professor of Psychiatry and Neurology
Director of Geriatric Psychiatry
Columbia University Medical Center
New York, NY
William Clay Jackson
William "Clay" Jackson, MD, DipTh, FAAFP
Assistant Professor of Clinical Psychiatry
Department of Family Medicine
University of Tennessee College of Medicine
Memphis, TN
Lead Physician
Department of Medicine
Methodist Medical Group-Atoka
Atoka, TN

Please note: No CME will be given to any accredited organization for this program and CME credits will not be given for attendance.

Minnesota, New Jersey, Vermont, and Federal Entities (e.g., the Department of Defense, the Department of Veterans Affairs, etc.) have restrictions on receiving in-kind benefits (e.g., meals, valet parking) at company-sponsored events. You are accountable for understanding such restrictions and complying with them. If you are licensed in or affiliated with any of these states or federal agencies, Genentech policies may restrict you from consuming any portion of the Genentech-sponsored meal at this program or from receiving any other in-kind benefit from Genentech (e.g., valet parking) in connection with the program.

When you RSVP please indicate whether you will accept or opt out of Genentech's in-kind benefits (e.g., meals, valet parking) at the program. If you choose to opt out you may either pay for the meal and parking on your own, or not consume anything at the program. For all program attendees who receive Genentech's in-kind benefits at this program, Genentech will report the attendee's name and the value received as required by federal and state disclosure laws (for more information on the federal law please visit sunshine.gene.com).

The meal value reported may vary by event location and be up to $150 per person (exceptions may apply).

Held in conjunction with the Alzheimer's Association International Conference 2019.

© 2019 Genentech USA, Inc. All rights reserved. GPT/051019/0027